Effect of Ramadan Fasting on Kidney Function and Proteinuria in Patients With Glomerulonephritis
Conditions: Fasting Ramadan Interventions: Behavioral: fasting month of ramadan Sponsors: Alexandria University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 25, 2024 Category: Research Source Type: clinical trials
Obinutuzumab in Treatment of Fibrillary Glomerulonephritis
Conditions: Fibrillary Glomerulonephritis Interventions: Drug: Obinutuzumab Sponsors: Mayo Clinic Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 6, 2024 Category: Research Source Type: clinical trials
Affection of Renal and Urinary System in IBD Patients
Conditions: Nephrolithiasis, Glomerulonephritis, Amyloidosis,AKI, CKD, Tubuli Interstitial; Urinary System Disorders in IBD Patients Sponsors: Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2024 Category: Research Source Type: clinical trials
Safety and Efficacy Study of OMS906 in Patients With C3G and ICGN
Conditions: C3 Glomerulopathy; Idiopathic Immune Complex-Mediated Glomerulonephritis Interventions: Drug: OMS906 study drug Sponsors: Omeros Corporation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 17, 2024 Category: Research Source Type: clinical trials
Assessment of the Association Between Metabolic Associated Fatty Liver Disease (MFLD) and Biopsy Proved Cases of GN
Conditions: Assessment of Patients With Biopsy Proven Primary Glomerulonephritis Above 18 Years of Age for MFLD Development Sponsors: Assiut University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 5, 2023 Category: Research Source Type: clinical trials
Prevalence and Pathological Features of C3 Dominant Glomerulonephritis Among Egyptian Population
Conditions: C3 Nephropathy Sponsors: Sohag University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 10, 2023 Category: Research Source Type: clinical trials
National Registry of Rare Kidney Diseases
Conditions: Adenine Phosphoribosyltransferase Deficiency; AH Amyloidosis; AHL Amyloidosis; AL Amyloidosis; Alport Syndrome; Atypical Hemolytic Uremic Syndrome; Autoimmune Distal Renal Tubular Acidosis; Autosomal Recessive Proximal Renal Tubular Acidosis; Autosomal Recessive Distal Renal Tubular Acidosis; Autosomal Dominant Polycystic Kidney Disease; Autosomal Recessive Polycystic Kidney Disease; Bartter Syndrome; BK Nephropathy; C3 Glomerulopathy With Monoclonal Gammopathy; C3 Glomerulopathy; Calciphylaxis; Crystalglobulinaemia; Crystal-storing Histiocytosis; Cystinosis; Cystinuria; Dense Deposit Disease; Dent Disease; Den...
Source: ClinicalTrials.gov - October 4, 2023 Category: Research Source Type: clinical trials
Developing a Pipeline to Employ RNA-Seq as a Complementary Diagnostic Tool in Rare Diseases
Conditions: Atypical Hemolytic Uremic Syndrome; Membranoproliferative Glomerulonephritis; Autosomal Dominant Polycystic Kidney; Healthy Intervention: Procedure: Skin biopsy Sponsor: Mario Negri Institute for Pharmacological Research Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 18, 2023 Category: Research Source Type: clinical trials
New Analytic Tools for aHUS and C3G Diagnosis
Conditions: Hemolytic-Uremic Syndrome; Membranoproliferative Glomerulonephritis; Healthy Intervention: Diagnostic Test: C3NEF assay Sponsor: Mario Negri Institute for Pharmacological Research Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials
